Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity ...

Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Eli Lilly and Co (NYSE: LLY) announced that it expects 2024 full-year worldwide revenue to be approximately $45.0 billion, ...

Interested in an oral alternative to Ozempic injections? You might be considering metformin, an FDA-approved type 2 diabetes ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

At 68, Bharat Shah reversed diabetes and improved his health by losing 11 kg in six months through a low-carb diet and ...

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...

The use of GLP-1 drugs sparked the term "Ozempic shaming" to describe the negative perceptions faced by those who choose ...

With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...

A woman who waited for four years on an NHS waiting list for weight-loss support has said she believes she could have avoided ...

Empagliflozin led to promising weight loss outcomes in patients with prediabetes and diabetes, with the results being more prominent in men than in women.